Effects of taurine on rat behaviors in three anxiety models

Pharmacology Biochemistry and Behavior

Volumn 83, Issue 2, 2006, Pages 271-276

  Kong, Wei Xi ^a   Chen, Si Wei ^a   Li, Yu Lei ^a   Zhang, Yi Jing ^a   Wang, Rui ^a   Min, Li ^a   Mi, Xiaojuan ^a  

^a SHENYANG PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

Anxiolytic; Diazepam; Hole board; Open field; Rat; Social interaction; Taurine

Indexed keywords

ANXIOLYTIC AGENT; DIAZEPAM; TAURINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANXIETY; ARTICLE; BEHAVIOR; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; DISEASE MODEL; DRUG EFFECT; GENERALIZED ANXIETY DISORDER; HEAD MOVEMENT; LOCOMOTION; MALE; MODULATION; NONHUMAN; OPEN FIELD TEST; PRIORITY JOURNAL; PSYCHOLOGIC TEST; RAT; SCORING SYSTEM; SOCIAL INTERACTION; TRANQUILIZING ACTIVITY;

ANIMALS; ANXIETY; BEHAVIOR, ANIMAL; INTERPERSONAL RELATIONS; MALE; MAZE LEARNING; RATS; RATS, WISTAR; TAURINE;

ANIMALIA;

EID: 33646071208     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pbb.2006.02.007     Document Type: Article

References (39)

1. Baskin S.I., Hinkamp D.L., Marquis W.J., and Tilson H.A. Effects of taurine on psychomotor activity in the rat. Neuropharmacology 13 (1974) 591-594
2. Becquet D., Hery M., Francois-Bellan A.M., Giraud P., Deprez P., Faudon M., et al. Glutamate, GABA, glycine and taurine modulate serotonin synthesis and release in rostral and caudal rhombencephalic raphe cells in primary cultures. Neurochem Int 23 3 (1993) 269-283 [Sep]
3. Benrabh H., Bourre J.-M., and Lefauconnier J.-M. Taurine transport at the blood-brain barrier: an in vivo brain perfusion study. Brain Res 692 (1995) 57-65
4. Bockelmann R., Reiser M., and Wolf G. Potassium-stimulated taurine release and nitric oxide synthase activity during quinolinic acid lesion of the rat striatum. Neurochem Res 23 4 (1998) 469-475 [Apr]
5. Cheeta S., Kenny P.J., and File S.E. Hippocampal and septal injections of nicotine and 8-OH-DPAT distinguish among different animal tests of anxiety. Prog Neuropsychopharmacol Biol Psychiatry 24 7 (2000) 1053-1067 [Oct]
6. Chen S.W., Kong W.X., Zhang Y.J., Li Y.L., Mi X.J., and Mu X.S. Possible anxiolytic effects of taurine in the mouse elevated plus-maze. Life Sci 75 (2004) 1503-1511
7. Colivicchi M.A., Bianchi L., Bolam J.P., Galeffi F., Frosini M., Palmi M., et al. The in vivo release of taurine in the striatonigral pathway. Adv Exp Med Biol 442 (1998) 363-370
8. Darstein M., Landwehrmeyer G.B., Kling C., Becker C.-M., and Feuerstein T.J. Strychnine-sensitive glycine receptors in rat caudaputamen are expressed by cholinergic interneurons. Neuroscience 96 (2000) 33-39
9. Dunn R.W., Corbett R., and Fielding S. Effects of 5-HT1A receptor agonists and NMDA receptor antagonists in the social interaction test and the elevated plus maze. Eur J Pharmacol 169 (1989) 1-10
10. File S.E., and Hyde J.R.G. Can social interaction be used to measure anxiety?. Br J Pharmacol 62 (1978) 19-24
11. File S.E., Kenny P.J., and Cheeta S. The role of the dorsal hippocampal serotonergic and cholinergic system in the modulation of anxiety. Pharmacol Biochem Behav 66 1 (2000) 65-72
12. Foos T.M., and Wu J.-Y. The role of taurine in the central nervous system and the modulation of intracellular calcium homeostasis. Neurochem Res 27 (2002) 21-26
13. Galarreta M., Bustamante J., Martin del Rio R., and Solis J.M. Taurine induces a long-lasting increase of synaptic efficacy and axon excitability in the hippocampus. J Neurosci 16 1 (1996) 92-102 [Jan]
14. Griebel G. 5-Hydroxytryptamine-interacting drugs in animal models of anxiety disorders: more than 30 years research. Pharmacol Ther 65 (1995) 319-395
15. Handley S.L., and MaBlane J.W. 5-HT drugs in animal models of anxiety. Psychopharmacology 112 (1993) 13-20
16. Higgins G.A., Jones B.J., and Oakley N.R. Effect of 5-HT1A receptor agonists in two models of anxiety after dorsal raphe injection. Psychopharmacology 106 (1992) 261-267
17. Hruska R.E., Thut P.D., Huxtable R.J., and Bressler R. Suppression of conditional drinking by taurine and related compounds. Pharmacol Biochem Behav 3 (1975) 593-599
18. Jacobsen J.G., and Smith L.H. Biochemistry and physiology of taurine and taurine derivatives. Physiol Rev 48 2 (1968) 424-511
19. Kamei J., Ohsawa M., Tsuji M., Takeda H., and Matsumiya T. Modification of the effects of benzodiazepines on the exploratory behaviors of mice on a hole-board by diabetes. Jpn J Pharmacol 86 (2001) 47-54
20. Kontro P., and Oja S.S. Interactions of taurine with GABAB binding sites in mouse brain. Neuropharmacology 29 3 (1990) 243-247 [Mar]
21. Kuriyama K. Symposium, taurine as a neuromodulator. Fed Proc 39 9 (1980) 2680-2684 [Jul]
22. Liljequist R. Interaction of taurine and related compounds with GABAergic neurones in the nucleus raphe dorsalis. Pharmacol Biochem Behav 44 (1992) 107-112
23. Lombardini J.B. High affinity uptake systems for taurine in tissue slices and synaptosomal fractions prepared from various regions of the rat central nervous system. Correction of transport data by different experimental procedures. J Neurochem 29 2 (1977) 305-312 [Aug]
24. Malminen O., and Kontro P. Actions of taurine on the GABA-benzodiazepine receptor complex by taurine in rat brain membranes. Neurochem Res 11 (1986) 85-94
25. McBride W.J., and Frederickson R.C. Taurine as a possible inhibitory transmitter in the cerebellum. Fed Proc 39 (1979) 2701-2705
26. Medina J.H., and De Robertis E. Taurine modulation of the benzodiazepine gamma-aminobutyric acid receptor complex in brain membranes. J Neurochem 42 (1984) 1212-1217
27. A receptors in mammalian brain in vitro. Eur J Pharmacol 207 (1991) 9-16
28. Milakofsky L., Hare A.T., Miller M.J., and Vogel H.W. Rat plasma levels of amino acids and released compounds during stress. Life Sci 36 (1984) 753-761
29. Min L., Chen S.W., Li W.J., Wang R., Li Y.L., Wang W.J., et al. The effects of angelica essential oil in social interaction and hole-board tests. Pharmacol Biochem Behav 81 4 (2005) 838-842 [Aug]
30. Molchanova S., Oja S.S., and Saransaari P. Characteristics of basal taurine release in the rat stratum measured by microdialysis. Amino Acids 27 3-4 (2004) 261-268 [Dec]
31. Oja S.S., and Kontro P. GABA, hypotaurine and taurine transport in brain slices from developing mouse. Dev Neurosci 6 (1984) 271-277
32. Sanberg P.R., and Ossenkopp K.-P. Dose-response effects of taurine on some open field behaviors in the rat. Psychopharmacology 53 (1977) 207-209
33. Saransaari P., and Oja S.S. Characterization of N-methyl-d-aspartate-evoked taurine release in the developing and adult mouse hippocampus. Amino Acids 24 (2003) 213-221
34. Sergeeva O.A., and Haas H.L. Expression and function of glycine receptors in striatal cholineric interneurons from rat and mouse. Neuroscience 104 (2001) 1043-1055
35. Serrano M.I., Goicoechea C., Serrano J.S., Serrano-Martino M.C., Sánchez E., and Martín M.I. Age-related changes in the antinociception induced by taurine in mice. Pharmacol Biochem Behav 73 (2002) 863-867
36. Sgaragli G., Carla V., Magnani M., and Galli A. Hypothermia induced in rabbits by intracerebroventricular taurine: specificity and relationship with central serotonin (5-HT) systems. J Pharmacol Exp Ther 219 (1981) 778-785
37. 3H] muscimol binding after buspirone pretreatment. Pharmacol Biochem Behav 66 3 (2000) 645-651
38. Smythe J.W., Murphy D., and Costall B. Benzodiazepine receptor stimulation blocks scopolamine-induced learning impairments in a water maze task. Brain Res Bull 41 5 (1996) 299-304
39. Takeda H., Tsuji M., and Matsumiya T. Changes in head-dipping behavior in the hole-board test reflect the anxiogenic and/or anxiolytic state in mice. Eur J Pharmacol 350 (1998) 21-29